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Abstract
Pluripotent embryonic stem cells hold a great promise as an unlimited source of tissue for treatment of chronic diseases
such as Type 1 diabetes. Herein, we describe a protocol using all-trans-retinoic acid, basic fibroblast growth factor and
dibutyryl cAMP (DBcAMP) in the absence of embryoid body formation, for differentiation of murine embryonic stem cells
into definitive endoderm that may serve as pancreatic precursors. The produced cells were analyzed by quantitative PCR,
immunohistochemistry and static insulin release assay for markers of trilaminar embryo, and pancreas. Differentiated cells
displayed increased Sox17 and Foxa2 expression consistent with definitive endoderm production. There was minimal
production of Sox7, an extraembryonic endoderm marker, and Oct4, a marker of pluripotency. There was minimal
mesoderm or neuroectoderm formation based on expression levels of the markers brachyury and Sox1, respectively. Various
assays revealed that the cell clusters generated by this protocol express markers of the pancreatic lineage including insulin I,
insulin II, C-peptide, PDX-1, carboxypeptidase E, pan-cytokeratin, amylase, glucagon, PAX6, Ngn3 and Nkx6.1. This protocol
using all-trans-retinoic acid, DBcAMP, in the absence of embryoid bodies, generated cells that have features of definitive
endoderm that may serve as pancreatic endocrine precursors.
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Introduction
Embryonic stem (ES) cells are pluripotent cells with the ability
to differentiate in vivo and in vitro into all cell types of the embryo
proper. These cells represent a potentially unlimited source of
differentiated cells or tissue for transplantation for common
diseases such as type 1 diabetes mellitus. During embryogenesis
in vivo, the liver and the pancreas arise from the definitive
endoderm [1] which is produced through the process of
gastrulation from the embryonic ectoderm of the epiblast [2].
Efficient production of definitive endoderm would allow for on-
demand production of pancreatic tissues.
Efforts have been devoted to producing glucose responsive
insulin producing (GRIP) cells from ES cells. Although initial
studies on the generation of GRIP cells seemed encouraging [3,4],
later work revealed that observed insulin expression resulted from
insulin uptake from the media rather than de novo synthesis [5,6].
More recently, D’amour et al., by using activin A, exendin,
cyclopamine and retinoic acid, showed that human embryonic
stem cells can differentiate into endocrine cells capable of
synthesizing pancreatic hormones [7]. The same group of
investigators went on to produce cells that express insulin and
C-peptide [8]. Since then, other scientists have differentiated
human ES cells into insulin producing cells [9].
Some protocols for differentiation of ES cells relied on the
formation of embryoid bodies (EBs) to initiate differentiation. EB
formation stimulates the chaotic differentiation of ES cells into all
three germ lineages: endoderm, ectoderm and mesoderm. During
EB formation in vitro, only a small fraction of differentiated
definitive endoderm derived cells arise while a preponderance of
ectoderm and mesodermal cells are generated. Since the large-
scale production of uniform EBs represents a bioprocess
engineering challenge and is not likely to yield pure populations
of endoderm cells, strategies to overcome the need for EB
formation are needed for establishing reliable and reproducible
protocols for generating universal ‘‘off-the-shelf’’ tissues for
transplantation.
During development, the visceral endoderm (primitive endo-
derm) and epiblast are derived from the inner cell mass of the
blastocyst [10,11]. In contrast to the visceral endoderm which is
displaced to the extraembryonic sac, the epiblast cells ingress
through the anterior segment of the primitive streak to form the
definitive endoderm that eventually contributes cells that develop
into the liver and pancreas [1,10,11,12]. To distinguish definitive
endoderm from other tissues, transcriptional factors such as Sry-
related HMG-box transcription factor Sox17 [13,14], the mix-like
gene MIXL1 [13,14,15], and Foxa 2 (previously known as the
hepatocyte nuclear factor (HNF) 3b) [16,17,18,19] have been used
as markers of definitive endoderm. An increase in expression of
these definitive endoderm markers (Sox 17, GSC, Foxa 2 (HNF3b)
and MIXL1) in combination with a concomitant decrease in
expression of primitive endoderm marker (Sox 7), mesoderm
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ZIC1) have been collectively used as evidence for production of
definitive endoderm.
Numerous factors have been proposed to promote definitive
endoderm differentiation. For example, high concentrations of
Activin A, a member of the transforming growth factor-beta
(TGF-b) superfamily have been reported to promote endoderm
formation [7,13,20,21]. All-trans-retinoic acid (RA) has been
shown to stimulate endoderm differentiation in teratocarcinoma
stem cells and this effect was potentiated by addition of dibutyryl
cyclic-AMP (DBcAMP) [22]. Retinoic acid has been implicated in
embryonic endodermal patterning, especially during early pan-
creas formation [23,24].
We hypothesized that by using a combination of all-trans-
retinoic acid, basic fibroblast growth factor (bFGF) and dibutyryl-
cyclic AMP, mouse embryonic stem cells can be differentiated into
tissues that express characteristics of definitive endoderm that may
serve as precursors for pancreatic endocrine cells.
Materials and Methods
All tissue cultures with ES cells and experiments involving
animals and their tissues were approved by the institutional animal
care and research ethics committees.
Generation of embryonic stem cells
ES cells were generated from C57BL/6 mouse 3.5 day post
coitum blastocyst stage embryos by plating the embryos into a 96
well dish with irradiated feeder cells (primary embryonic
fibroblasts, PEFs) and ES cell media consisting of high glucose
containing Dulbecco’s modified Eagle media (DMEM) supple-
mented with 15% fetal bovine serum (FBS), 100 U/ml+100 mg/
ml penicillin (100 U/ml)-streptomycin (100 mg/ml), 100 mM2 -
mercaptoethanol, 2 mM glutamine, 1 mM sodium pyruvate,
0.1 mM non-essential amino acids and 10 ng/ml Leukemia
Inhibitory Factor [4] in the presence of 25 mg of PD98059 as
described by Buehr and Smith [25]. Blastocysts were incubated at
37uC with 5% CO2. Approximately 2–3 days after plating, when
the blastocysts have adhered and the cells have started to grow out,
they were trypsinized and replated in ES cell media.
Cell Culture and Differentiation
Step 1: Embryonic Stem Cell Maintenance. C57BL/6
mouse ES cells were cultured on a feeder layer of gamma
irradiated PEFs and incubated at 37uC with 95% O2/5% CO2 in
an ES cell maintenance medium comprised of 15% FBS (Gemini
Bio-Products, Woodland, CA), 1 mM sodium pyruvate (Stem Cell
Technologies, Vancouver, Canada), 2 mM glutamine (Stem Cell
Technologies), 0.1 mM non-essential amino acids (Stem Cell
Technologies), 10 ng/ml leukemia inhibitory factor (Chemicon
International, Temecula, CA), 100 mM 1-thioglyercol (MTG)
(Sigma, St. Louis, MO) and high glucose DMEM (Stem Cell
Technologies) for 2–3 days until they were 70–80% confluent. The
cells from this step are represented with ‘‘1’’ in Figure 1 and
throughout other figures.
Step 2. As illustrated in Figure 1, ES cells were dissociated
with trypsin/EDTA solution and plated onto 100 mm gelatinized
tissue culture dishes in 1:10 dilutions and incubated at 37uC with
95% O2/5% CO2 with 15% FBS, 0.1 mM non-essential amino
acids, 1 mM MTG, 2 mM of L-glutamine, 10
27 M of all-trans-
retinoic acid (Sigma) and 25 ng/ml of human basic fibroblast
growth factor (bFGF) (Stem Cell Technologies), and high glucose
DMEM for 3 days. The cells are represented by the number 2.
Step 3. The cells generated in step 2 were then maintained at
37uC with 95% O2/5% CO2 with 15% FBS containing high
glucose DMEM supplemented with 0.1 mM non-essential amino
acids, 1 mM MTG, 2 mM of L-glutamine in the presence of
25 ng/ml of bFGF for up to 14 days. At this time the cells were
trypsinized, harvested, plated onto petri dishes, and incubated for
6 days in suspension at 37uC with 95% O2/5% CO2 with ES-Cult
basal medium-A with 1x N2 supplement-A (Stem Cell
Technologies), bFGF, 1x B27 supplement (Stem Cell
Technologies) to facilitate formation of cell clusters (represented
by number 3).
Step 4. The cell clusters from Step 3 were cultured for 6 days
at 37uC with 95% O2/5% CO2 in the presence of 2610
23 M
dibutyryl cAMP in ES-Cult basal medium-A supplemented with
1x N2 supplement and 10 mM nicotinamide (represented by
number 4).
Immunohistochemistry
The Step 4 cell clusters were fixed in 4% formalin and
subsequently embedded in paraffin. The paraffin blocks were
deparaffinized in xylene, rehydrated in graded ethanol and washed
in phosphate buffered saline (PBS). Antigen retrieval was necessary
prior to immunostaining for most antibodies (10 mM citrate
buffer; pH 6.0). Sections were incubated for 1 hour with blocking
buffer containing 2–5% serum followed by incubation with
primary antibodies for 1 hour at room temperature or overnight
at 4uC. Sections were washed and incubated with respective
secondary antibodies for 1 hour at room temperature. The
primary antibodies used were rabbit anti-mouse PDX-1 (1:500,
Chemicon, Temecula, CA), rabbit anti-mouse Ngn3 (1:500, a gift
from Dr. F. Lynn), mouse anti-carboxypeptidase E (CPE) (1:500,
BD Biosciences, San Jose, CA), rabbit anti-pan-cytokeratin (1:100,
Santa Cruz Biotechnology, Santa Cruz, CA), guinea pig anti-
human insulin (1:100, Dako, Glostrup, Denmark), rabbit anti-
human glucagon (1:75, Dako), goat anti-rat antibody for C-peptide
made with purified synthetic rat C-peptide II (1:100, Linco
Research, St. Charles, MO), mouse anti-mouse somatostatin
Figure 1. An overview of the culture protocol. The ES cells were
taken out of LIF, and plated in the presence of all-trans-retinoic acid and
bFGF (Step 2, denoted by 2) for 3 days followed by media without the
retinoic acid but in the presence of bFGF for 14 days. These cells were
then grown in suspension in the presence of N2 and B27 for 6 days
(Step 3, denoted by 3) before being put into media containing DBcAMP
and nicotinamide for 6 days (Step 4, denoted by 4).
doi:10.1371/journal.pone.0014146.g001
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pig anti-rat pancreatic polypeptide (1:1000, Linco), goat anti-
human ghrelin (1:100, Santa Cruz) and rabbit anti-human
amylase (1:2000, Sigma). The secondary antibodies used included
Alexa 594 or 488 anti-guinea pig, mouse, rabbit, or rat (1:200,
Jackson Immuno Research, West Grove, PA). All antibodies were
diluted in PBS with 1% BSA or in blocking buffer (PBS with 2–5%
serum).
Quantitative PCR (Q-PCR)
RNA was isolated from cells in each step using TRIZOL
reagent (Invitrogen, Burlington, ON, Canada) according to the
manufacturer’s instructions. The isolated RNA was treated with
DNAse (Invitrogen) and quantified with an UltrospecH 3000
spectrophotometer (Pharmacia Biotech Ltd, Cambridge, UK).
The primers used are listed in Table 1. In order to demonstrate
enrichment for definitive endoderm relative to other germ lineages
the following transcripts were analyzed: Sox 17 and Foxa 2 for
definitive endoderm; brachyury for mesoderm; Sox 7 for primitive
endoderm; and Sox 1 for ectoderm. Marker of pluripotency, Oct-4
was used to document the extent of differentiation. The markers of
pancreatic precursors and differentiating beta cells, Nkx6.1, PDX-
1 and Insulin I and II, were used to look for evidence of pancreatic
lineage. To further verify beta cell lineage differentiation, levels of
islet amyloid polypeptide (IAPP) and islet-specific glucose-6-
phosphatase (IGRP) were also measured. PAX 6 was used as a
pre-beta cell endocrine cell marker [26,27]. Amylase was used as a
marker of exocrine pancreas. PAX 6 and neurogenin (Ngn) 3 were
used as endocrine markers. Prevalidated primers for Sox 7, Sox1,
brachyury, Ngn3 and PDX-1 were purchased from Applied
Biosystems (Foster City, CA). All other primers were designed
using Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_
www.cgi) and spanned introns where possible (Table 1). Amplicons
were between 80–120 bp for efficient amplification. Primer
efficiencies were determined using an exponential cDNA dilution
series. Only primer pairs with an efficiency greater than 0.8 were
used in subsequent analyses. A 7500 Real Time PCR System
(Applied Biosystems) and SYBR Green PCR master mix (Applied
Biosystems) were used for all reactions. cDNAs were generated by
reverse transcription (RT) of 1 mg of total RNA from newly isolated
tissue for each RT. 10 ng of generated cDNA was used in each
reaction with all reactions done in duplicate. Samples were
normalized to beta-actin, and the fold increase compared to Step
1 as calculated using 2
2DDCT [28] as appropriate unless otherwise
noted.
Insulin Release Assay
The Step 4 cell clusters, recovered in insulin free, low glucose
recovery medium composed of Ham’s F12/DMEM (no glucose)
(Gibco/Invitrogen) and 10 mM nicotinamide overnight, were
washed in Krebs-Ringer bicarbonate buffer (KRBB) with 0.1%
BSA in 1.67 mM D-glucose. Total insulin content of the cells was
determined by lysing of cells in 1 M glacial acetic acid and
quantifying insulin levels by radioimmunoassay. In a separate
experiment, to assess for glucose responsive insulin release from
the cluster, the clusters were first washed in KRBB with 0.1% BSA
in 1.67 mM D-glucose and then exposed to either 1.67 mM or
16.7 mM D-glucose in KRBB with 0.1% BSA for 2 hours. Insulin
radioimmunoassay (RIA) was performed to determine the levels of
murine insulin I and II using a human insulin radioimmunoassay
kit according to the manufacturer’s instructions (MP Biomedicals,
Irvine, CA). The insulin content was calibrated per mg DNA
(determined using an UltrospecH 3000 spectrophotometer;
Pharmacia Biotech Ltd, Cambridge, UK).
Transmission Electron Microscopy
To assess whether these cells have mechanisms for secretion,
transmission electron microscopy [29] was performed to look for
secretory granules in the cytoplasm. The step 4 clusters were fixed
in EM grade 4% formaldehyde and embedded in Lowicryl K4M
resin. Ultra thin sections were prepared on an RMC MT-6000-
XL ultramicrotome (Sorvall, Microtomes, Wilmington, DE) and
examined for the presence of secretory granules with Hitachi
H7600 transmission electron microscope.
Results
Endoderm Differentiation
Production of definitive endoderm from murine ES cells was
assessed in three different ways. First, the markers of definitive
endoderm (Sox 17 and Foxa 2) were quantified in the different
steps of the protocol. Second, the marker of primitive endoderm,
Sox 7, was measured to ensure that any observed expression of
Sox 17 and Foxa 2 did not arise from primitive endoderm where
these two markers may also be expressed. Finally, levels of Sox 1
(neuroectoderm marker) and brachyury (mesoderm marker) were
measured to determine if there was preferential differentiation to
the definitive endoderm lineage.
As illustrated in Figure 2, there was an upregulation of definitive
endoderm markers: Sox17 (13 fold) and Foxa 2 (6 fold) in the latter
steps of the protocol relative to their respective expression in
embryonic stem cells (Step 1). In contrast, the primitive endoderm
marker Sox 7, showed only a marginal increase in expression in
steps 3 and 4. Moreover, the Sox 7 primer consistently produced
high Ct values (.30) suggesting that only nominal levels of this gene
were expressed. Similarly, the mesoderm marker brachyury and the
neuroenctoderm marker Sox 1 did not increase appreciably and
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expressed at very low levels throughout the protocol (Figure 2)
supporting decreased pluripotency of the cells and adequate
differentiation away from the embryonic stem cell stage.
Taken together, the quantitative PCR results suggest that the
protocol here produces definitive endodermal tissues from murine
ES cells. These observations are consistent with those of D’Amour
et al. [13] and suggest that the production of definitive endoderm
using this approach arises from a more preferential differentiation
rather than a differentiation as a part of all three germ layers. It is
possible that some of the expression of the definitive endoderm
markers have been contributed by extraembryonic endoderm.
There is evidence in the literature that the combination of RA and
DBcAMP can induce production of extraembryonic endoderm
[30,31,32,33]. However, based on the data, the contribution of
Sox 17 and Foxa 2 by primitive endoderm is likely minimal.
Production of Cells of Pancreatic Lineage
Quantitative PCR and Immunohistochemistry. The
generation of cells of the pancreatic lineage was assessed by
measuring expression levels of the following markers: IAPP, IGRP,
insulin I and insulin II (beta cell markers), the transcriptional
regulators Nkx 6.1 and PDX-1 (pancreas development markers)
and an endocrine marker, PAX 6 using Q-PCR. Another
pancreatic endocrine marker Ngn3 was expressed at increasing
levels throughout the differentiation protocol. In addition,
fluorescence immunohistochemistry was performed to determine
cellular protein levels of insulin, glucagon, C-peptide, PDX-1,
Ngn-3, carboxypeptidase E (CPE), pan-cytokeratin (pan-CK),
somatostatin, pancreatic polypeptide and ghrelin.
The Q-PCR analyses revealed an approximately 100 fold
increase in expression of insulin I and insulin II in the last step of
the protocol (Figure 3). Of note is the observation that insulin I,
which is produced only in the pancreas, progressively increased
with each step. In contrast, insulin II, which is produced not only
in the pancreas, but also in fetal liver, neurons and yolk sac
[34,35], was expressed at a constant level throughout steps 2–4. In
keeping with the Q-PCR results, a small proportion of the cells in
the step 4 clusters were positive for insulin (Figure 4). Both Nkx6.1
and PAX 6, markers of endocrine differentiation increased
throughout the differentiation process. Other beta cell markers
IAPP and IGRP showed an increase with the differentiation steps.
There was some production of exocrine pancreatic tissue as
evidenced by an increased production of amylase in the last step of
the protocol (Figure 3). In contrast, PDX-1 levels were increased
during steps 2 and 3, prior to decreasing during step 4.
Figure 2. Quantitative PCR results of definitive endoderm markers (Sox 17 and FOXA2), mesoderm marker (brachyury),
neuroectoderm marker (Sox 1), primitive endoderm marker (Sox 7), and pluripotency marker (Oct 4) in the cells cultured by the
protocol. The expression of each gene is illustrated as expression of SYBR green (semi-log scale on Y axis) relative to its level in ES cells (1).
doi:10.1371/journal.pone.0014146.g002
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cluster were necrotic, likely from the fact that these were cultured in
suspension and the delivery of nutrients in the media was
compromised to the cells in the inner core. Most clusters express
Ngn3, whereas the expression of PDX-1 was markedly lower. A
small proportion of cells were positive for islet markers such as
insulin,C-peptideandglucagon.Also,asmallproportion ofthecells
expressed CPE and pan-CK. CPE was used as an additional islet
marker and pan-CK was used as an exocrine pancreatic marker
(ductal). Notably, the CPE staining was cytoplasmic and punctate,
compatible with granular localization, whereas PDX-1 stain was
perinuclear in distribution as expected. There was a progressive
increase in the expression of amylase and this implies production of
exocrine pancreatic tissues. The cell clusters did not express
somatostatin, pancreatic polypeptide or ghrelin (data not shown).
Characterization of the step 4 cells. To characterize the
step 4 cells, insulin (insulin I and II) content was quantified. The
insulin radioimmunoassay used reliably detects both insulin I and
II. The Step 4 cell clusters had a total insulin content of
50.467.1 mIU/ml/mg of DNA. As outlined in Table 2, the
stimulated insulin release assay revealed high basal levels of insulin
secretion (17.263.1%) at low glucose concentrations (1.67 mM)
with a significant increase at high glucose concentrations
(16.7 mM), (29.361.1%, p,0.03). To assess the step 4 clusters
for cells that possess mechanisms for secretion, TEM was
performed on these cells to identify secretory granules in the
cytoplasm. As illustrated in Figure 5, these cells have mulitple
secretory granules.
Discussion
Generation of definitive endoderm from ES cells is the first
essential step toward generation of pancreatic tissues. In this
manuscript, we describe a protocol that has produced a population
of cells that express characteristics of definitive endoderm. This
protocol does not require formation of EBs, but culturing of cells in
Figure 3. Quantitative PCR results of pancreatic markers (insulin-I, insulin-II, IAPP, IGRP, amylase, PDX-1, Nkx 6.1) and endocrine
markers (PAX6 and Ngn 3) in the cells cultured by the protocol. The expression of each gene is illustrated as expression of SYBR green (semi-
log scale in the Y-axis) relative to its levels in ES cells (1).
doi:10.1371/journal.pone.0014146.g003
ES-Derived Endoderm
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include uniform exposure of cells to the reagents in the media and
enhanced ease of handling of the cells. This may possibly help
reproducibility and facilitate process scale up.
Since the work by D’Amour et al. suggested a criteria for
accepted markers of definitive endoderm [13], a combination of
the increase of markers such as Sox 17, GSC, Foxa 2 and MIXL1
and a decrease in the primitive endoderm markers that are not
expressed in definitive endoderm such as Sox 7 needs to be
included to support the argument for production of definitive
endoderm. Furthermore, a decrease in the markers expressed in
other germ layers (i.e. ectoderm and mesoderm) would suggest that
Figure 4. Immunohistochemistry of cell clusters for pancreatic endocrine markers insulin (Ins), C-peptide (CP), carboxypeptidase E
(CPE), neurogenin 3 (Ngn3), PDX-1, and glucagon (Glu). Exocrine pancreatic marker pan-cytokeratin (panCK) was also present. The nuclear
marker DAPI is included in each figure. Scale bar represents 50 um.
doi:10.1371/journal.pone.0014146.g004
Table 2. Glucose-stimulated insulin release.
Cell Clusters
% Insulin Secretion Glucose
Concentrations P value
1.67 mM 16.7 mM
Step 4 (4) 17.263.1 29.361.1 0.03
Total insulin (insulin I and II) secretion in response to exposure to low (1.67 mM)
and high (16.7 mM) glucose concentration for the cell clusters from Step 4 (4).
Student’s t-test was used to determine the differences in percent secretion.
doi:10.1371/journal.pone.0014146.t002
ES-Derived Endoderm
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definitive endodermal cells.
In this study, RA and DBcAMP appeared to induce
production of definitive endoderm from ES cells when they
were cultured with serum and bFGF for an extended period of
time as evidenced by an expression of Sox 17 and Foxa 2. Also,
there were minimal levels of Sox 1 and brachyury suggesting
that there was no significant production of neuroectodermal and
mesodermal tissues. This observation is in keeping with previous
studies indicating that RA plays an important role in the
development of the murine dorsal pancreas [36] and induces
production of PDX-1 positive endoderm [37] in an ES cell
differentiation model that involves EB formation. Further
evidence that RA facilitates this differentiation process is the
observation that Fibroblast growth factor 2 (FGF2) binds
transmembrane fibroblast growth factor receptors and plays a
key role in mouse embryogenesis, including development of the
pancreas and liver [38,39,40]. FGF2 signaling has also been
suggested to play an important role in development of the
exocrine pancreas [41] and in maintenance of adult beta cell
function [42]. In liver development, FGF2 signaling from the
cardiac mesoderm induces hepatogenesis [43], and furthermore,
FGF2 signaling appears to stimulate expression of sonic
hedgehog which in turn inhibits pancreatic development [38].
FGF2 has been shown to be important in pancreatic
development and maintenance of beta cell function, suggesting
that FGF2 may promote pancreatic differentiation. In a separate
experiment, exposing the cells to FGF2 for a shorter period of
time resulted in lower insulin content in cells (data not shown).
During normal development, mature beta cells develop after
formation of definitive endoderm, and the glucose responsive
insulin release is a feature of mature beta cells. The expression of
definitive endoderm markers increased throughout the four steps
of the protocol. In addition, the expression levels of several
markers indicative of pancreas differentiation, including Nkx6.1,
Pax6 and insulin I, also progressively increased whereas the
expression of Pdx-1, a transcriptional regulator that plays critical
roles in pancreas specification and development, as well as beta
cell function appeared to peak at step 3 and then decreased during
step 4. Collectively, these data suggest that the differentiation
protocol promoted the progressive maturation of ES cells towards
definitive endoderm and pancreatic lineage. The expression of
Nkx6.1, PAX 6, Ngn3, IAPP, IGRP, CPE, Insulin I, C-peptide
and PDX-1 in the cell population suggests that a subpopulation of
cells in Step 4 were endocrine cell precursors. Furthermore, Step 4
cells also contained a small subset of mature glucose responsive
insulin producing cells as supported by the immunohistochemistry
and insulin release data.
In summary, the ES cell differentiation protocol described in
this study resulted in the generation of cells that displayed
characteristics of definitive endoderm. There is a production of a
small number of heterogeneous population of cells that express
characteristics of pancreatic tissues; however, most cells appear to
be in the pancreatic endocrine precursor stage. The insulin
production from the cells in this protocol is not significant and
further analysis is required to elucidate the nature and the origin of
the insulin producing cells. Studies are underway to assess the
efficiency of the protocol for endoderm production.
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